Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation

NARecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

April 29, 2023

Primary Completion Date

October 29, 2024

Study Completion Date

April 29, 2026

Conditions
Parkinson Disease
Interventions
DEVICE

gamma transcranial alternating current stimulation (tACS)

Transcranial alternating current stimulation (tACS) will be delivered using a BrainSTIM (EMS, Italy) connected to two electrodes (5x5cm) enclosed in sponges soaked with saline solution. One electrode will be centred over the first dorsal interosseus (FDI) hotspot and the other over P3. tACS will be delivered at peak-to-peak amplitude of 1 milliampere (mA), and with 3-seconds ramp-up and down periods. The stimulation frequency will be 70 Hz, as representative of the endogenous motor network-related gamma frequency.

DEVICE

sham transcranial alternating current stimulation (tACS)

Sham-tACS will consist of ramp-up and down periods and only 1-second stimulation at 1 mA amplitude.

Trial Locations (1)

Unknown

RECRUITING

IRCCS Neuromed, Pozzilli

All Listed Sponsors
collaborator

Fondazione Policlinico Universitario Campus Bio-Medico

OTHER

collaborator

I.R.C.C.S. Fondazione Santa Lucia

OTHER

lead

Neuromed IRCCS

OTHER